Course Catalog
Browse our full catalog of continuing education courses and events
Browse Courses & Events
From Numbers to Navigation: Translating Data From Diabetes Technologies into Optimized Decision-Making
Diana Isaacs, PharmD, BCACP, CDCES, BC-ADM, FADCES, FCCP; Robert H. Eckel, MD; Javier Morales, MD, F...
Live Tumor Board: Multidisciplinary Strategies to Prevent and Manage ADC-Associated Pulmonary Toxicities in Ovarian Cancer
Kathleen N. Moore, MD, MS, FASCO; Rachel N. Grisham, MD; Rohit Gupta, MD; Maida Hafiz, MD
Rapid Reviews in Retina™: Emerging Updates from Winter 2026 – Addressing the Wealth of New Data in Treatments for nAMD, DME, and RVO
Judy E. Kim, MD, FARVO, FASRS; Prethy Rao, MD, MPH, FACS
Medical Crossfire®: DLL3-Directed Therapies in Small Cell Lung Cancer—A Nursing-Centered Approach to a New Era of Care
Alissa J. Cooper, MD; Kelly Goodwin, NP; Stephanie J. McDonald, MSN, FNP-BC, AOCNP; Rebecca W. Repet...
Show Me the Data®: From Mutation to Action — KRAS as a Therapeutic Target in PDAC
E. Gabriela Chiorean, MD; Tanios S. Bekaii-Saab, MD; Mitesh Borad, MD; Christopher Lieu, MD
Optimizing HER2 Testing in Gastroesophageal Adenocarcinoma: Laying the Foundation for Targeted Therapy
Yelena Y. Janjigian, MD; Michal F. Segal, BSN, OCN
Clinical Crossroads™: Delayed Identification of Hypercortisolism – What Are the Risks?
Yehuda Handelsman, MD, FACP, FNLA, FASPC, FAHA, MACE
Oncology Town Hall: Translating the Latest Updates Into the Care of Patients With AML in Community Practice
Eunice Wang, MD; Hetty Carraway, MD, MBA; Naval G. Daver, MD
Cases and Conversations™: Integrating PSMA-Directed Radioligand Therapy in Prostate Cancer Care: Recent Data and Evolving Strategies
Mary-Ellen Taplin, MD; Jeremie Calais, MD, PhD; Himanshu Nagar, MD, MS
Lupus Nephritis Postgame: Takeaways from our Expert Faculty
Shivani Garg, MD, PhD; Samir V. Parikh, MD, FASN
Show Me the Data™: Post-TKI Sequencing in EGFR-Mutated NSCLC—Optimizing Current Strategies and Preparing for New Treatment Modalities
Christine M. Lovly, MD, PhD, FASCO; Xiuning Le, MD, PhD; Hossein Borghaei, DO, MS; Lyudmila Bazhenov...
Medical Crossfire® — From Diagnostic Dilemmas to Potential Treatment Breakthroughs: Exploring Novel Targets for Extrapulmonary Neuroendocrine Carcinomas
David S. Klimstra, MD; Danielle A. Hutchings, MD; Nancy M. Joseph, MD, PhD; Jonathan Strosberg, MD
26th Annual International Congress on the Future of Breast Cancer® East
July 23-24, 2027
Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer
Sanja Dacic, MD, PhD; Soo-Ryum (Stewart) Yang, MD; Isabel Preeshagul, DO, MBS
Community Practice Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer
Neil M. Iyengar, MD; Sara M. Tolaney, MD, MPH
Burst CME Expert Illustrations & Commentaries™: Breaking Down DLL3-Targeting Immune Cell Effector Agents in SCLC
Jacob Sands, MD; Anne Chiang, MD, PhD
Collaborating Across the Continuum®: Tying the Threads: Screening, Referrals, and Optimized Treatments in MASLD/MASH
Nancy Reau, MD; Conan Tu, MD; Sonal Kumar, MD, MPH
Publication Review: Defining On-Treatment Remission in Plaque Psoriasis
April W. Armstrong, MD, MPH; Tina Bhutani-Jacques MD
Virtual Hot Seat: How the Experts Target the PI3K/AKT/mTOR Pathway in HR+/HER2– Metastatic Breast Cancer
Rebecca Shatsky, MD; Maxwell Roger Lloyd, MD; Sarah Sammons, MD; Sherry Shen, MD
How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients
Michael Levy, MD, PhD; Jeffrey L. Bennett, MD, PhD; Eoin P. Flanagan, MB, BCh
OncoBytes Adaptive Learning Pathways: Personalizing Treatment Plans to Optimize Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer
Joyce O’Shaughnessy, MD; Virginia Kaklamani, MD, DSc; Seth A. Wander, MD, PhD
Medical Crossfire®: Translating Risk into Action—Redefining Adjuvant Strategies for Early HR+/HER2– Breast Cancer
Ann H. Partridge, MD, MPH; William J. Gradishar, MD, FASCO, FACP; Saranya Chumsri, MD
Cases and Conversations: Translating ctDNA Into Clinical Decisions in Breast Cancer
Neil M. Iyengar, MD; Kelly Elizabeth McCann, MD, PhD; Wassim Mchayleh, MD, MBA, FACP
Reducing Treatment Burden in Retinal Disease Care With Extended-Duration Anti-VEGF Therapies
John Kitchens, MD
Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension
Geeta Lalwani, MD; Alla Goldberg, MD; Elite Bor-Shavit, MD
Emerging Therapeutic Advancements in Dry Eye Disease Management
Rahul Tonk, MD; Jade Coats, OD, FAAO; Aaleya Koreishi, MD; Zeba Syed, MD
Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management
Murtaza K. Adam, MD, FASRS; Deepak Sambhara, MD, FASRS; Betty Zhang, OD
Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck - Post-CRT Decisions in the Locally Advanced Setting
Quynh-Thu Le, MD, FACR, FASTRO; Vlad C. Sandulache, MD, PhD
Show Me the Data®: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD
Carrie L. Kitko, MD; Miguel-Angel Perales, MD; Amandeep Salhotra, MD
Coffee Talk: Charting New Pathways with HER2 and TROP2 Therapies – From Early to Advanced Breast Cancer
Hope S. Rugo, MD, FASCO; Paolo Tarantino, MD, PhD; Alastair Thompson, MD, MBChB, BSc (Hons), FRCS (E...
Facilitating Precision Pathways: Surgical Considerations in Breast Cancer for Tackling Barriers to Genetic Testing and Targeted Therapies
Patrick I. Borgen, MD; Don S. Dizon, MD, FACP, FASCO; Kevin S. Hughes, MD, FACS; Banu Arun, MD, FASC...
Show Me the Data™: Translating Clinical and Practice-Based Evidence on Oral SERDs Into Everyday Care for HR+/HER2– Metastatic Breast Cancer
Reshma L. Mahtani, DO; Kamel Abou Hussein, MD; Irene Kang, MD
Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management
Mary Qiu, MD; Paul Singh, MD; Danica J. Marrelli, OD, FAAO
26th Annual International Congress on the Future of Breast Cancer® West
July 16-17, 2027
Medical Crossfire®: Optimizing 𝘌𝘚𝘙1 Mutation Detection and Next-Generation Endocrine Therapy Integration in HR+/HER2– Breast Cancer
VK Gadi, MD, PhD; Neil M. Iyengar, MD; Heather McArthur, MD, MPH
Medical Crossfire®: Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment
Ashish M. Kamat, MD, MBBS; Katie S. Murray, DO, MS; Thomas Powles, MD, MBBS, MRCP
New Precision Strategies for HER2+ GEA: Interpreting New Data to Inform Clinical Practice
Rahul Gosain, MD, MBA; Rohit Gosain, MD; Sunnie Kim, MD; Samuel L. Cytryn, MD
Medical Crossfire®: Advancing Personalized Care in TNBC—Integrating Biomarkers, Clinical Evidence, and Emerging Therapies
Adam Brufsky, MD, PhD; Kamel Abou Hussein, MD; Priyanka Sharma, MD, FASCO
Medical Crossfire®: Redefining Frontline and Maintenance Strategies in HER2+ Metastatic Breast Cancer
Joyce O’Shaughnessy, MD; Reshma L. Mahtani, DO; Heather McArthur, MD, MPH; Paolo Tarantino, MD, PhD
Medical Crossfire®: Expanding Options, Evolving Challenges in Advanced HR+/HER2– Breast Cancer: How Experts Apply the Latest Data
Kevin Kalinsky, MD, MS; Adam Brufsky, MD, PhD; Kelly Elizabeth McCann, MD, PhD; Sara Nunnery, MD, MS...
From Molecular Insights to Clinical Impact: Translating the Latest Advances in Menin Inhibitors Into Practice
Naval G. Daver, MD; Amir Fathi, MD; Guillermo Garcia-Manero, MD; Aditi Shastri, MD
Current and Future Directions in Precision-Based ALL Therapy
Elias Jabbour, MD; Hagop M. Kantarjian, MD; Aaron C. Logan, MD, PhD, MPhil














































